Physical activity and exercise Not Applicable
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Overweight and/or obese (BMI 25-35), and/or at increased risk of type 2 diabetes as determined by their General Practitioner (GP) 2. Not currently taking any prescribed medication for cardiovascular or metabolic conditions
Exclusion criteria
Exclusion criteria: 1. Not classified as overweight or obese 2. Not deemed to be at increased risk of Type 2 diabetes as determined by their General Practitioner (GP) 3. Currently taking prescribed medication for cardiovascular or metabolic conditions
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measured pre and post (12 weeks) intervention: 1. Body composition, including BF mass (kg), lean mass (kg) and BF percentage (%), measured using bio-impedance (Bodystat 1500, Bodystat, Isle of Man, UK). Guidelines from the National Institute of Health Research Southampton Biomedical Research Centre were followed for body compositions assessment (http://www.uhs.nhs.uk/Media/Southampton-Clinical-Research/Procedures/BRCProcedures/Procedure-for-bioimpedance-with-Bodystat-1500.pdf) 2. Predicted 1RM for chest press, pull down and leg press, obtained by gauging the maximal weight that could be lifted successfully for between 5 and 15 repetitions, and inputting these data into the Brzycki equation (i.e. weight/(1.0278-(0.0278 x No. Repetitions)). These results were collapsed into a single strength measure (the mean of the predicted 1RM for each exercise) | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured pre and post (12 weeks) intervention: 1. Maximal aerobic capacity (VO2max) predicted using the Modified Balke Protocol. Participants walked on a treadmill at between 3.6 and 5.6kph, depending on ability, for 3 min. Following this, the gradient was increased by 1% each minute. Ratings of perceived exertions recorded at 1-min intervals using the OMNI1–10 scale. Oxygen consumption and heart rate continuously monitored via direct gaseous analysis (Fitmate Pro, COSMED, Italy). Predicted VO2max automatically extrapolated using the relationship with heart rate. The test was terminated when participants indicated perceived exertion above six (hard) and/or their heart rate reached 150bpm 2. Mean arterial pressure (MAP), which describes the average arterial pressure during a single cardiac cycle, incorporating both systolic and diastolic phases, but weighted towards the diastolic. Systolic (SBP) and diastolic (DBP) blood pressures (mmHg) were measured using a commercially available blood pressure monitor (Omron Healthcare, Japan). Three readings were collected and the mean value reported. MAP was estimated via the calculation MAP=DBP+0.33(SBP-DBP) | — |
Countries
United Kingdom